Natural Killer (NK) Cell Therapeutics Global Market Report 2025
상품코드:1760642
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
자연살해(NK) 세포 치료 시장 규모는 향후 몇 년 동안 12.3%의 연평균 성장률(CAGR)로 2029년까지 63억 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 임상시험 증가, 면역치료 연구개발 투자 증가, 고형암에 대한 적용 확대, 전략적 제휴, 세포 치료에 대한 규제 당국의 지원, 맞춤형 암 치료에 대한 수요 증가 등의 요인에 의해 이루어질 것으로 보입니다. 예측 기간의 주요 동향으로는 유전공학의 혁신, CAR-NK 치료의 발전, 세포 확대 기술의 개선, 임상시험 활동의 혁신, 기성품 NK 세포 제품 개발, 고형암 치료의 발전 등을 들 수 있습니다.
암의 유병률 증가는 향후 몇 년 동안 자연살해(NK) 세포 치료 시장의 성장을 견인할 것으로 예상됩니다. 암은 통제할 수 없는 비정상적인 세포의 증식을 동반하며, 주변 조직에 침입하여 신체의 다른 부위로 퍼져 정상적인 세포 조절을 방해하고 종양을 형성하여 신체 기능을 손상시킵니다. 오염물질, 담배 연기, 화학제품 노출과 같은 환경적 요인은 DNA를 손상시키고 세포 기능을 방해하여 암의 위험을 증가시키는데, NK세포 치료는 사전 감작 없이 종양 세포를 직접 표적으로 삼아 제거함으로써 암을 치료합니다. 예를 들어, 미국 비영리단체인 미국암협회는 2024년 4월, 2022년에 전 세계적으로 2,000만 명이 새로 암 진단을 받고 970만 명이 암으로 사망할 것으로 예상되며, 2050년에는 인구 증가로 인해 암 환자 수가 3,500만 명으로 증가할 것으로 예측하고 있습니다. 결과적으로 암 유병률의 증가는 NK세포 치료 시장 확대에 박차를 가하고 있습니다.
주요 기업들은 비용 효율적인 기성품 NK 세포 치료를 가능하게 하기 위해 확장 가능한 iPSC 기반 NK 세포 제조 플랫폼 개발과 같은 진보에 집중하고 있습니다. 이 플랫폼은 인공만능줄기세포(iPSC)를 사용하여 표준화된 피더가 필요 없는 폐쇄형 바이오리액터 환경에서 NK세포를 생산하여 높은 수율과 규제 준수를 보장합니다. 예를 들어, 2025년 4월 벨기에에 본사를 둔 생명공학 기업 셀리스틱(Cellistic)은 NK 세포 치료를 위한 iPSC 기반 제조 솔루션인 Echo-NK 플랫폼을 발표했습니다. 이 플랫폼은 혈액암, 고형암, 자가면역질환을 표적으로 하는 NK세포의 확장 가능한 생산을 가능하게 하며, 모든 주요 증식 공정은 Cellistic의 EMA 인증 GMP 시설 내 폐쇄형 바이오리액터에서 이루어집니다. Echo-NK 플랫폼은 셀리스틱의 펄스 세포주 개발 역량과 독자적인 STAR-CRISPR 기술을 접목하여 특정 유전자 편집이 적용된 안정적인 iPSC 세포주 개발을 가속화하고, 기성품 NK 세포 치료를 위한 상업적으로 실행 가능한 솔루션을 제공합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 거시경제 시나리오 : 금리·인플레이션·지정학·무역 전쟁·관세·코로나와 회복이 시장에 미치는 영향을 포함한다
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 자연살해(NK) 세포 치료 시장 : PESTEL 분석(정치·사회·기술·환경·법적 요인, 촉진요인, 억제요인)
최종 이용 산업 분석
세계의 자연살해(NK) 세포 치료 시장 : 성장률 분석
세계의 자연살해(NK) 세포 치료 시장 규모·성장률 : 실적치, 2019-2024년
세계의 자연살해(NK) 세포 치료 시장 규모·성장률 : 예측치, 2024-2029년, 2034년
세계의 자연살해(NK) 세포 치료 시장 : 총유효과 시장(TAM)
제6장 시장 세분화
세계의 자연살해(NK) 세포 치료 시장 : 치료법별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
NK 세포 표적 항체
NK 세포 치료
세계의 자연살해(NK) 세포 치료 시장 : 용도별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
면역 증식성 질환
소화기질환
암
기타 용도
세계의 자연살해(NK) 세포 치료 시장 : 유통 채널별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
병원 약국
직접 입찰
기타 유통 채널
세계의 자연살해(NK) 세포 치료 시장 : 최종사용자별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
연구·학술기관
병원
전문 클리닉
세계의 자연살해(NK) 세포 치료 시장 : NK세포 표적 항체 종류별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
단클론항체(mAb)
이중특이성항체(BsAb)
항체약물접합체(ADC)
세계의 자연살해(NK) 세포 치료 시장 : NK 세포 치료 종류별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
자가 NK 세포 치료
동종 NK 세포 치료
CAR(키메라 항원 수용체)-NK 세포 치료
제7장 지역별·국가별 분석
세계의 자연살해(NK) 세포 치료 시장 : 지역별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
세계의 자연살해(NK) 세포 치료 시장 : 국가별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
자연살해(NK) 세포 치료 시장 : 경쟁 구도
자연살해(NK) 세포 치료 시장 : 기업 개요
Sanofi S.A.(개요, 제품 및 서비스, 전략, 재무 분석)
Thermo Fisher Scientific(개요, 제품 및 서비스, 전략, 재무 분석)
Lonza AG(개요, 제품 및 서비스, 전략, 재무 분석)
Catalent(개요, 제품 및 서비스, 전략, 재무 분석)
Kite Pharma(개요, 제품 및 서비스, 전략, 재무 분석)
제31장 기타 주요 기업과 혁신적 기업
Fate Therapeutics
Artiva Biotherapeutics
Nkarta, Inc
Celularity Inc.
NKGen Biotech
Dragonfly Therapeutics
Cytovia Therapeutics
Glycostem Therapeutics
Gamida Cell
ONK Therapeutics
Wugen Inc.
AGC Biologics
CytoImmune Therapeutics
XNK Therapeutics
Indapta Therapeutics
제32장 세계 시장 : 경쟁 벤치마킹·대시보드
제33장 주요 기업 인수합병(M&A)
제34장 최근의 시장 동향
제35장 시장 잠재력 높은 나라·부문과 전략
자연살해(NK) 세포 치료 시장 : 최신 기회를 제공하는 국가(2029년)
자연살해(NK) 세포 치료 시장 : 최신 기회를 제공하는 부문(2029년)
자연살해(NK) 세포 치료 시장 : 성장 전략(2029년)
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Natural killer (NK) cell therapeutics are treatments that utilize or boost NK cells, a type of immune cell, to identify and eliminate cancer cells, infected cells, or other abnormal cells. These therapies encompass NK cell infusions (autologous/allogeneic), CAR-NK cells (genetically engineered to target specific proteins), and NK-targeting antibodies (bispecific antibodies).
The primary forms of NK cell therapeutics are NK cell-targeting antibodies and NK cell-based treatments. NK cell-targeting antibodies are designed to enhance NK cells' capacity to detect and destroy cancer cells by binding to tumor-specific antigens. These therapies are used in areas such as cancer, immunoproliferative disorders, gastrointestinal conditions, and more. Distribution methods include hospital pharmacies, direct tenders, and additional channels, while the main end-users are hospitals, specialty clinics, and research and academic institutions.
The natural killer (nk) cell therapeutics market research report is one of a series of new reports from The Business Research Company that provides natural killer (nk) cell therapeutics market statistics, including the natural killer (nk) cell therapeutics industry global market size, regional shares, competitors with the natural killer (nk) cell therapeutics market share, detailed natural killer (nk) cell therapeutics market segments, market trends, and opportunities, and any further data you may need to thrive in the natural killer (nk) cell therapeutics industry. This natural killer (nk) cell therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The natural killer (NK) cell therapeutics market size has grown rapidly in recent years. It will grow from $3.52 billion in 2024 to $3.96 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. The growth during the historical period can be attributed to factors such as the rise in cancer incidence, increased R&D funding, greater awareness of immunotherapy, growth in strategic industry partnerships, enhanced regulatory support, and advancements in cell expansion technologies.
The natural killer (NK) cell therapeutics market size is expected to see rapid growth in the next few years. It will grow to $6.3 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The projected growth during the forecast period is driven by factors including an increase in clinical trials, rising investment in immunotherapy R&D, expanding applications in solid tumors, strategic collaborations, regulatory support for cell therapies, and growing demand for personalized cancer treatments. Key trends in the forecast period involve innovations in genetic engineering, advancements in CAR-NK therapies, improvements in cell expansion techniques, innovation in clinical trial activities, the development of off-the-shelf NK cell products, and progress in treatments for solid tumors.
The increasing prevalence of cancer is expected to drive the growth of the natural killer (NK) cell therapeutics market in the coming years. Cancer involves the uncontrolled growth of abnormal cells that invade nearby tissues and spread to other parts of the body, disrupting normal cell regulation, forming tumors, and impairing bodily functions. Environmental factors, such as exposure to pollutants, tobacco smoke, and chemicals, can damage DNA and disturb cellular functions, increasing the risk of cancer. NK cell therapeutics treat cancer by directly targeting and eliminating tumor cells without the need for prior sensitization. For example, the American Cancer Society, a U.S.-based non-profit organization, reported in April 2024 that in 2022, 20 million new cancer cases were diagnosed, and 9.7 million people died from the disease worldwide. It is predicted that by 2050, the number of cancer cases will rise to 35 million, driven primarily by population growth. As a result, the growing prevalence of cancer is fueling the expansion of the NK cell therapeutics market.
Major companies are focusing on advancements such as developing scalable iPSC-based NK cell manufacturing platforms to enable cost-effective, off-the-shelf NK cell therapies. These platforms use induced pluripotent stem cells (iPSCs) to generate NK cells in a standardized, feeder-free, closed-system bioreactor environment, ensuring high yields and regulatory compliance. For instance, in April 2025, Belgium-based biotechnology company Cellistic launched the Echo-NK platform, an iPSC-based manufacturing solution for NK cell therapies. This platform enables scalable production of NK cells targeting blood cancers, solid tumors, and autoimmune diseases, with all key expansion steps conducted in bioreactor closed systems within Cellistic's EMA-certified GMP facility. By incorporating Cellistic's Pulse cell line development capabilities and proprietary STAR-CRISPR technology, the Echo-NK platform accelerates the development of stable iPSC cell lines with specific gene edits, offering a commercially viable solution for off-the-shelf NK cell therapies.
In March 2025, AstraZeneca, a British-Swedish multinational pharmaceutical and biotechnology company, acquired EsoBiotec for up to $1 billion, which includes an initial payment of $425 million and up to $575 million in milestone-based contingent payments. AstraZeneca intends to utilize EsoBiotec's platform to make cell therapies more accessible, scalable, and affordable for cancer patients worldwide, marking a significant expansion in its cell therapy portfolio. EsoBiotec is a Belgian-based biotech company specializing in cell therapeutics development.
North America was the largest region in the natural killer (NK) cell therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in natural killer (NK) cell therapeutics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the natural killer (NK) cell therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The natural killer (NK) cell therapeutics market includes revenues earned by entities by providing services such as scell therapy development, clinical trial support, contract manufacturing, regulatory consulting, and cell line engineering. The market value includes the value of related goods sold by the service provider or included within the service offering. The natural killer (NK) cell therapeutics market also includes sales of cytokine-activated NK cells, CAR-NK cell therapies, cell expansion kits, reagents, and culture media. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Natural Killer (NK) Cell Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on natural killer (nk) cell therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for natural killer (nk) cell therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The natural killer (nk) cell therapeutics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
3. Natural Killer (NK) Cell Therapeutics Market Trends And Strategies
4. Natural Killer (NK) Cell Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Natural Killer (NK) Cell Therapeutics Growth Analysis And Strategic Analysis Framework
5.1. Global Natural Killer (NK) Cell Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.1. Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Natural Killer (NK) Cell Directed Antibodies
Natural Killer (NK) Cell Therapies
6.2. Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immunoproliferative Disorders
Gastrointestinal Diseases
Cancer
Other Applications
6.3. Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Direct Tender
Other Distribution Channels
6.4. Global Natural Killer (NK) Cell Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Research And Academic Institutes
Hospitals
Specialty Clinics
6.5. Global Natural Killer (NK) Cell Therapeutics Market, Sub-Segmentation Of Natural Killer (NK) Cell Directed Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monoclonal Antibodies (mAbs)
Bispecific Antibodies (BsAbs)
Antibody-Drug Conjugates (ADCs)
6.6. Global Natural Killer (NK) Cell Therapeutics Market, Sub-Segmentation Of Natural Killer (NK) Cell Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Autologous NK Cell Therapies
Allogeneic NK Cell Therapies
Chimeric Antigen Receptor (CAR)-NK Cell Therapies
7. Natural Killer (NK) Cell Therapeutics Market Regional And Country Analysis
7.1. Global Natural Killer (NK) Cell Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Natural Killer (NK) Cell Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Natural Killer (NK) Cell Therapeutics Market
9.1. China Natural Killer (NK) Cell Therapeutics Market Overview
9.2. China Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Natural Killer (NK) Cell Therapeutics Market
10.1. India Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Natural Killer (NK) Cell Therapeutics Market
11.1. Japan Natural Killer (NK) Cell Therapeutics Market Overview
11.2. Japan Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Natural Killer (NK) Cell Therapeutics Market
12.1. Australia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Natural Killer (NK) Cell Therapeutics Market
13.1. Indonesia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Natural Killer (NK) Cell Therapeutics Market
14.1. South Korea Natural Killer (NK) Cell Therapeutics Market Overview
14.2. South Korea Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Natural Killer (NK) Cell Therapeutics Market
15.1. Western Europe Natural Killer (NK) Cell Therapeutics Market Overview
15.2. Western Europe Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Natural Killer (NK) Cell Therapeutics Market
16.1. UK Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.1. Germany Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Natural Killer (NK) Cell Therapeutics Market
18.1. France Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.1. Spain Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Natural Killer (NK) Cell Therapeutics Market
21.1. Eastern Europe Natural Killer (NK) Cell Therapeutics Market Overview
21.2. Eastern Europe Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Natural Killer (NK) Cell Therapeutics Market
22.1. Russia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Natural Killer (NK) Cell Therapeutics Market
23.1. North America Natural Killer (NK) Cell Therapeutics Market Overview
23.2. North America Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Natural Killer (NK) Cell Therapeutics Market
24.1. USA Natural Killer (NK) Cell Therapeutics Market Overview
24.2. USA Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Natural Killer (NK) Cell Therapeutics Market
26.1. South America Natural Killer (NK) Cell Therapeutics Market Overview
26.2. South America Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Natural Killer (NK) Cell Therapeutics Market
27.1. Brazil Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Natural Killer (NK) Cell Therapeutics Market
28.1. Middle East Natural Killer (NK) Cell Therapeutics Market Overview
28.2. Middle East Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Natural Killer (NK) Cell Therapeutics Market
29.1. Africa Natural Killer (NK) Cell Therapeutics Market Overview
29.2. Africa Natural Killer (NK) Cell Therapeutics Market, Segmentation By Therapeutics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Natural Killer (NK) Cell Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Natural Killer (NK) Cell Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Natural Killer (NK) Cell Therapeutics Market Competitive Landscape And Company Profiles
